The data, as reported by Variety, paints a clear picture of renewed interest. In September, "The Dropout" saw its viewership jump by an impressive 186% compared to the previous month. This momentum continued into October, with the week of October 12 alone registering a 92% increase in hours watched over the preceding week. To put this into perspective, the series garnered as many views in that single week as it did throughout the entire month of August, before the new documentary's existence became widely known.

Prior to this surge, "The Dropout," which originally premiered in 2022, was already performing respectably for a four-year-old series, accumulating 420,000 hours watched in August. However, September's figures soared to 1.2 million hours, an estimated 176,000 views. As of mid-October, total viewership since September has reached an astonishing 2.2 million hours, or approximately 296,000 estimated views, indicating sustained engagement.

This renewed fascination with the Elizabeth Holmes narrative began with the September 6 announcement of "You Can See Everything," a documentary directed by Nathan Fielder and Lance Oppenheim, which had been produced in secret and premiered at the Telluride Film Festival. Its subsequent wide release on October 16 only intensified public curiosity.

The impact of the documentary extends beyond "The Dropout." Streaming guide JustWatch noted a 200% week-over-week increase in search points for the Hulu series following the documentary's release, propelling it to the No. 10 spot on the site's streaming search rankings. Furthermore, John Carreyrou's 2018 investigative book, "Bad Blood: Secrets and Lies in a Silicon Valley Startup," which exposed Holmes' fraudulent enterprise, has also made a return to the New York Times bestseller list, highlighting a broader "Elizabeth Holmes mania" gripping audiences.

"The Dropout" itself was a critical darling upon its release, earning Amanda Seyfried an Emmy for her compelling portrayal of Holmes. Creator Elizabeth Meriwether and Seyfried had previously expressed interest in revisiting the story, with Seyfried quipping to Variety, "I'm not kidding, a two hour special!" While Seyfried has been more reserved about future projects recently, the current viewership surge certainly underscores the enduring appeal of the Theranos scandal and its central figure.